The Ross procedure is a heart surgery that replaces a diseased aortic valve with the patient’s own pulmonary valve. A donor valve is then placed in the pulmonary position to take over that role. First performed by surgeon Donald Ross in 1967, it remains the only aortic valve replacement that uses living tissue from the patient’s own body, which means the new valve can grow, adapt, and function almost identically to a normal aortic valve.
How the Surgery Works
The heart has four valves, and two of them are structurally similar: the aortic valve (which controls blood flow from the heart to the rest of the body) and the pulmonary valve (which directs blood to the lungs). The Ross procedure takes advantage of this similarity by swapping one for the other.
During the operation, the surgeon opens the chest, places the patient on a heart-lung bypass machine, and inspects both valves. If the pulmonary valve looks healthy, the surgeon removes the diseased aortic valve and carefully cuts out the pulmonary valve along with a section of the artery around it. This pulmonary valve is then sewn into the aortic position. The coronary arteries, which supply blood to the heart muscle itself, are reattached to the transplanted tissue. Finally, a preserved donor valve (called a homograft, typically from a deceased donor) is placed where the pulmonary valve used to be. An echocardiogram is performed before closing to confirm both valves are working properly.
This is a technically demanding operation. It essentially turns a single-valve problem into a two-valve surgery, which is one reason it’s performed at specialized centers by experienced surgical teams.
Why Use Your Own Valve
The core advantage is that your pulmonary valve is living tissue. Unlike a mechanical valve or an animal-tissue valve, it responds to your body the way a native valve does. Blood flows through it with pressure gradients nearly identical to a healthy aortic valve. In studies comparing Ross patients to people with normal hearts, the blood flow characteristics at rest and during peak exercise were essentially the same.
This translates into real, measurable benefits. A systematic review published in JAMA Cardiology found that Ross procedure patients had significantly lower pressure gradients across their aortic valve compared to those with prosthetic replacements, with a mean difference of about 10 mm Hg. Lower gradients mean the heart doesn’t have to work as hard to push blood through, which protects long-term heart function. Researchers believe this improved blood flow profile is a key reason Ross patients tend to show enhanced survival over time.
The other major benefit is freedom from blood thinners. Mechanical valves require lifelong anticoagulation medication, which carries roughly a 1% per year risk of serious bleeding or blood clots. In matched comparisons, Ross procedure patients experienced significantly fewer major bleeding events and strokes than those with mechanical valves. For younger patients who may live with their valve for decades, avoiding those cumulative risks is substantial.
Who It’s Best Suited For
The Ross procedure is primarily considered for younger and middle-aged adults with aortic valve disease who want to avoid lifelong blood thinners. It’s particularly appealing for people who lead active lives, women planning future pregnancies (since anticoagulation drugs carry risks during pregnancy), and competitive athletes.
Not everyone is a candidate. The procedure is generally not recommended for people with connective tissue disorders like Marfan syndrome, autoimmune conditions such as lupus or rheumatoid arthritis, coronary artery disease affecting three or more arteries, or existing pulmonary valve disease. Since the surgery depends on having a healthy pulmonary valve to transplant, any abnormality found during inspection can halt the procedure.
Performance During Exercise
One of the most striking findings about the Ross procedure comes from studying athletes. In a study comparing 11 conditioned athletes who had undergone the procedure to 13 age-matched healthy athletes, the results were remarkably close. Ross athletes reached a maximum heart rate of 188 beats per minute. Blood flow velocity across their aortic valve during peak exercise averaged 190 cm per second, virtually identical to the 190 cm per second measured in the normal group. The pressure gradient across the valve during maximum exertion was 16.3 mm Hg in the Ross group compared to 14.6 mm Hg in healthy controls.
In practical terms, the transplanted pulmonary valve performs like a normal aortic valve even under the demands of competitive athletics. This is something no mechanical or bioprosthetic valve can match.
Long-term Survival and Durability
Long-term data on the Ross procedure are encouraging but come with important caveats. In-hospital mortality is low, around 0.9%. Survival rates at 1 year are approximately 98%, at 10 years about 94%, and at 20 years roughly 81%.
The tradeoff is that both valves involved in the surgery may eventually need additional intervention. At 20 years, about 41% of patients required a reoperation on the transplanted valve in the aortic position, and about 16% needed work on the donor valve in the pulmonary position. The combined rate of any valve reintervention at 20 years was 45%. Most of these reoperations happen gradually over time: at 10 years the combined reintervention rate is closer to 16%.
These numbers mean the Ross procedure is not a permanent, one-time fix for everyone. But for a young patient who might otherwise face 40 or 50 years of blood thinner use with a mechanical valve, or multiple replacements with a bioprosthetic valve that wears out in 10 to 15 years, the calculus can still favor the Ross approach.
Autograft Dilation: The Main Concern
The most common long-term complication is dilation of the transplanted valve, meaning the tissue stretches over time under the higher pressures of the aortic position. In one study, this occurred in about 19% of patients, with freedom from dilation at 10 years around 82%.
Several factors increase this risk. Patients who already had a dilated aortic root before surgery, younger patients, and males were all more likely to develop dilation. Surgical technique also matters: operations performed before 2001, before modern reinforcement techniques became standard, carried a higher risk. Current approaches often include wrapping or reinforcing the transplanted tissue to prevent it from stretching, which appears to reduce this complication.
Recovery After Surgery
Recovery follows the general timeline of open-heart surgery. Most patients spend several days in the hospital, with the initial days in intensive care. Full recovery from the chest incision typically takes six to eight weeks, during which heavy lifting and strenuous activity are restricted. Return to normal daily activities usually happens within that window, while clearance for vigorous exercise or competitive sports comes later, often around three to six months depending on individual healing and cardiac function.
Because no blood thinners are needed afterward, the recovery period is simpler in one important respect: patients don’t have to manage the dietary restrictions, frequent blood tests, and bleeding risks that come with anticoagulation therapy. For many, this simplicity in daily life is as meaningful as the surgical outcome itself.